205 related articles for article (PubMed ID: 20540777)
1. Enhanced effector function of cytotoxic cells in the induced sputum of COPD patients.
Urbanowicz RA; Lamb JR; Todd I; Corne JM; Fairclough LC
Respir Res; 2010 Jun; 11(1):76. PubMed ID: 20540777
[TBL] [Abstract][Full Text] [Related]
2. Altered effector function of peripheral cytotoxic cells in COPD.
Urbanowicz RA; Lamb JR; Todd I; Corne JM; Fairclough LC
Respir Res; 2009 Jun; 10(1):53. PubMed ID: 19545425
[TBL] [Abstract][Full Text] [Related]
3. Differential activation of killer cells in the circulation and the lung: a study of current smoking status and chronic obstructive pulmonary disease (COPD).
Wang J; Urbanowicz RA; Tighe PJ; Todd I; Corne JM; Fairclough LC
PLoS One; 2013; 8(3):e58556. PubMed ID: 23505535
[TBL] [Abstract][Full Text] [Related]
4. Enhanced cytotoxic function of natural killer and natural killer T-like cells associated with decreased CD94 (Kp43) in the chronic obstructive pulmonary disease airway.
Hodge G; Mukaro V; Holmes M; Reynolds PN; Hodge S
Respirology; 2013 Feb; 18(2):369-76. PubMed ID: 23062183
[TBL] [Abstract][Full Text] [Related]
5. Increased numbers of NK cells, NKT-like cells, and NK inhibitory receptors in peripheral blood of patients with chronic obstructive pulmonary disease.
Tang Y; Li X; Wang M; Zou Q; Zhao S; Sun B; Xu L; Jiang Y
Clin Dev Immunol; 2013; 2013():721782. PubMed ID: 24069043
[TBL] [Abstract][Full Text] [Related]
6. Perforin expression and cytotoxic activity of sputum CD8+ lymphocytes in patients with COPD.
Chrysofakis G; Tzanakis N; Kyriakoy D; Tsoumakidou M; Tsiligianni I; Klimathianaki M; Siafakas NM
Chest; 2004 Jan; 125(1):71-6. PubMed ID: 14718423
[TBL] [Abstract][Full Text] [Related]
7. Human CD56+ cytotoxic lung lymphocytes kill autologous lung cells in chronic obstructive pulmonary disease.
Freeman CM; Stolberg VR; Crudgington S; Martinez FJ; Han MK; Chensue SW; Arenberg DA; Meldrum CA; McCloskey L; Curtis JL
PLoS One; 2014; 9(7):e103840. PubMed ID: 25078269
[TBL] [Abstract][Full Text] [Related]
8. Systematic characterization of human CD8+ T cells with natural killer cell markers in comparison with natural killer cells and normal CD8+ T cells.
Ohkawa T; Seki S; Dobashi H; Koike Y; Habu Y; Ami K; Hiraide H; Sekine I
Immunology; 2001 Jul; 103(3):281-90. PubMed ID: 11454057
[TBL] [Abstract][Full Text] [Related]
9. Induced sputum CD8+ T-lymphocyte subpopulations in chronic obstructive pulmonary disease.
Tzanakis N; Chrysofakis G; Tsoumakidou M; Kyriakou D; Tsiligianni J; Bouros D; Siafakas NM
Respir Med; 2004 Jan; 98(1):57-65. PubMed ID: 14959815
[TBL] [Abstract][Full Text] [Related]
10. Increased airway granzyme b and perforin in current and ex-smoking COPD subjects.
Hodge S; Hodge G; Nairn J; Holmes M; Reynolds PN
COPD; 2006 Dec; 3(4):179-87. PubMed ID: 17361498
[TBL] [Abstract][Full Text] [Related]
11. CD8
Kumari S; Shivam P; Hansa J; Jamal F; Singh MK; Bimal S; Narayan S; Pandey K; Das VNR; Das P; Singh SK
Hum Immunol; 2018 Aug; 79(8):616-620. PubMed ID: 29842895
[TBL] [Abstract][Full Text] [Related]
12. Sputum T lymphocytes in asthma, COPD and healthy subjects have the phenotype of activated intraepithelial T cells (CD69+ CD103+).
Leckie MJ; Jenkins GR; Khan J; Smith SJ; Walker C; Barnes PJ; Hansel TT
Thorax; 2003 Jan; 58(1):23-9. PubMed ID: 12511714
[TBL] [Abstract][Full Text] [Related]
13. Characterization of circulating T-, NK-, and NKT cell subsets in patients with colorectal cancer: the peripheral blood immune cell profile.
Krijgsman D; de Vries NL; Skovbo A; Andersen MN; Swets M; Bastiaannet E; Vahrmeijer AL; van de Velde CJH; Heemskerk MHM; Hokland M; Kuppen PJK
Cancer Immunol Immunother; 2019 Jun; 68(6):1011-1024. PubMed ID: 31053876
[TBL] [Abstract][Full Text] [Related]
14. Distribution of γδ and other T-lymphocyte subsets in patients with chronic obstructive pulmonary disease and asthma.
Urboniene D; Babusyte A; Lötvall J; Sakalauskas R; Sitkauskiene B
Respir Med; 2013 Mar; 107(3):413-23. PubMed ID: 23273406
[TBL] [Abstract][Full Text] [Related]
15. Ex vivo expansion of CD56+ NK and NKT-like lymphocytes from peripheral blood mononuclear cells of patients with ovarian neoplasia.
Alves PCM; De Angelo Andrade LAL; Petta CA; Lorand-Metze I; Derchain SF; Guimarães F
Scand J Immunol; 2011 Sep; 74(3):244-252. PubMed ID: 21595734
[TBL] [Abstract][Full Text] [Related]
16. Bronchiolitis obliterans syndrome is associated with increased peripheral blood natural killer and natural killer T-like granzymes, perforin, and T-helper-type 1 pro-inflammatory cytokines.
Hodge G; Hodge S; Holmes-Liew CL; Reynolds PN; Holmes M
J Heart Lung Transplant; 2012 Aug; 31(8):888-95. PubMed ID: 22759800
[TBL] [Abstract][Full Text] [Related]
17. Blood cytotoxic/inflammatory mediators in non-eosinophilic asthma.
Hodge S; Hodge G; Simpson JL; Yang IA; Upham J; James A; Gibson PG; Reynolds PN;
Clin Exp Allergy; 2016 Jan; 46(1):60-70. PubMed ID: 26767492
[TBL] [Abstract][Full Text] [Related]
18. CD56
Jaime P; García-Guerrero N; Estella R; Pardo J; García-Álvarez F; Martinez-Lostao L
Osteoarthritis Cartilage; 2017 Oct; 25(10):1708-1718. PubMed ID: 28668542
[TBL] [Abstract][Full Text] [Related]
19. Inflammatory cell profiles and T-lymphocyte subsets in chronic obstructive pulmonary disease and severe persistent asthma.
Tsoumakidou M; Tzanakis N; Kyriakou D; Chrysofakis G; Siafakas NM
Clin Exp Allergy; 2004 Feb; 34(2):234-40. PubMed ID: 14987303
[TBL] [Abstract][Full Text] [Related]
20. Cytotoxic potential of lung CD8(+) T cells increases with chronic obstructive pulmonary disease severity and with in vitro stimulation by IL-18 or IL-15.
Freeman CM; Han MK; Martinez FJ; Murray S; Liu LX; Chensue SW; Polak TJ; Sonstein J; Todt JC; Ames TM; Arenberg DA; Meldrum CA; Getty C; McCloskey L; Curtis JL
J Immunol; 2010 Jun; 184(11):6504-13. PubMed ID: 20427767
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
